If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
CAMBRIDGE, Mass.–(HSMN NewsFeed)–Idera Pharmaceuticals, Inc. (Nasdaq: IDRA ) today announced the election of Malcolm MacCoss, Ph.D., FRSC, to the Company’s Board of Directors as a class II director. Dr. MacCoss has nearly 30 years of drug discovery and d…
Biopharmaceuticals, Personnel
Idera Pharmaceuticals
Posts from ‘January, 2010’
Idera Pharmaceuticals Announces the Appointment of Malcolm MacCoss, Ph.D., to Its Board of Directors
Phadia Brings the First and Only Point of Care In Vitro Specific IgE Allergy Test into the Physician’s Office with Final FDA Clearance of the ImmunoCAP(R) Rapid System
PORTAGE, Mich.–(HSMN NewsFeed)–Phadia, the world leader in allergy blood testing diagnostics, today announced that the United States Food and Drug Administration (FDA) has cleared the ImmunoCAP® Rapid Reader II, a part of the ImmunoCAP Rapid System, …
Diagnostics, FDA
Phadia, ImmunoCAP Rapid, allergy
Novo Nordisk’s Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
PRINCETON, NJ - (HSMN NewsFeed) - Novo Nordisk (NYSE:NVO ) announced that the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza(R) (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1…
Biopharmaceuticals, Endocrinology, FDA
Novo Nordisk, Victoza, liraglutide, glucagon-like peptide
Cardium Provides Update on Commercial Development Plans for Generx Angiogenic Therapy for Heart Disease at 2010 Cell and Gene Therapy Forum
SAN DIEGO, Jan. 26 (HSMN NewsFeed) — Cardium Therapeutics (NYSE Amex: CXM) reported today that its Cardium Biologics division provided an update on plans for the continuing commercial development of Generx(TM) (alferminogene tadenovec, Ad5FGF-4), a DNA-…
Biopharmaceuticals, Cardiology, Regenerative Medicine
Cardium Therapeutics, Generx, alferminogene tadenovec, angiogenesis
Medtronic Receives FDA Approval for First Replacement Heart Valve Implanted without Surgery
Melody(R) Transcatheter Pulmonary Valve Offers Non-Surgical Valve Replacement Option for Congenital Heart Disease Patients MINNEAPOLIS–(HSMN NewsFeed)–In a significant development for congenital heart disease patients, Medtronic, Inc. (NYSE: MDT ), an…
Devices, Interventional Cardiology, FDA
Medtronic, Transcatheter Pulmonary Valve, Pulmonary Valve, heart valve
Two Combination Treatment Regimens Added to Updated NCCN Guidelines for Ovarian Cancer
The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Guidelines for Ovarian Cancer to include two additional combination treatment regimens for women with select types of recurring ovarian cancer FORT WASHINGTON, Pa.–(HSMN NewsFee…
Biopharmaceuticals, Oncology
Bristol-Myers Squibb, Centocor Ortho Biotech, NCCN, Taxol, Doxil, ovarian cancer
Calibra Receives 510(k) Clearance for the Finesse Insulin Patch-Pen, a Novel Way to Deliver Insulin
Finesse(TM) Creates a New Category of Insulin Delivery Devices That Target the Problem of Patient Adherence With Simple, Affordable and Discrete Insulin Management REDWOOD CITY, Calif.–(HSMN NewsFeed)–Calibra Pharmaceutical announced today that the U.S. Food…
Devices, Drug Delivery, Endocrinology, FDA
Calibra Pharmaceutical, insulin patch-pen
PolyTouch Medical Ltd. Announces The Appointment of William Edelman as Chairman of the Board
MISGAV, Israel, January 25 (HSMN NewsFeed) — PolyTouch Clinical Ltd., a major developer of hernia mesh placement technologies today announced that it has appointed William (Bill) Edelman as Chairman. Mr. Edelman brings over 32 years of experience in…
Devices, Surgery, Personnel
PolyTouch Clinical laboratory
Wolf Clinical laboratory is Free to Sell Its Redi-Flo(TM) Infusion Pump After a Ruling from the Court of Appeals in the I-Flow Case
SUNRISE, Fla., Jan. 21 (HSMN NewsFeed) — Wolf Pharma Supply, Inc. was granted an important favorable ruling by the Court of Appeals in their ongoing litigation with I-Flow Corporation, a division of Kimberly-Clark Corporation, regarding the Redi-Flo(TM…
Devices, Litigation
Wolf Clinical Supply, I-Flow, Redi-Flo, Infusion Pump
Shionogi Pharmaceutical Appoints Ray Russo as Vice President, Primary Care Business Unit
ATLANTA–(HSMN NewsFeed)–Shionogi Pharma, Inc. today announced that Ray Russo has joined the Company as Vice President, Primary Care Business Unit, reporting to Joe Ciaffoni, Executive Vice President and Chief Commercial Officer. In his new career opportunity, Mr. …
Biopharmaceuticals, Personnel
Shionogi Pharma
